Antibiotic resistance: Current perspectives

ACS Omega

Volumn 2, Issue 10, 2017, Pages 7400-7409

  Petchiappan, Anushya ^a   Chatterji, Dipankar ^a  

^a INDIAN INSTITUTE OF SCIENCE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85032687462     PISSN: None     EISSN: 24701343     Source Type: Journal    
DOI: 10.1021/acsomega.7b01368     Document Type: Review

References (46)

1. World Health Organization. Antibacterial Agents in Clinical Development: An Analysis of the Antibacterial Clinical Development Pipeline, Including Tuberculosis; WHO: Geneva, 2017, WHO/EMP/ IAU/2017.12.
2. Fleming, A. On the antibacterial action of cultures of a Penicillium, with special reference to their use in the isolation of B. influenzae. Br. J. Exp. Pathol. 1929, 10, 226-236.
3. Brown, E. D.; Wright, G. D. Antibacterial drug discovery in the resistance era. Nature 2016, 529, 336-343.
4. Blair, J. M.; Webber, M. A.; Baylay, A. J.; Ogbolu, D. O.; Piddock, L. J. Molecular mechanisms of antibiotic resistance. Nat. Rev. Microbiol. 2015, 13, 42-51.
5. Rice, L. B. Federal funding for the study of antimicrobial resistance in nosocomial pathogens: no ESKAPE. J. Infect. Dis. 2008, 197, 1079-1081.
6. Kerantzas, C. A.; Jacobs, W. R., Jr. Origins of Combination Therapy for Tuberculosis: Lessons for Future Antimicrobial Development and Application. mBio 2017, 8, No. e01586.
7. Smith, T.; Wolff, K. A.; Nguyen, L. Molecular biology of drug resistance in Mycobacterium tuberculosis. Curr. Top. Microbiol. Immunol. 2013, 374, 53-80.
8. Katayama, Y.; Ito, T.; Hiramatsu, K. A new class of genetic element, staphylococcus cassette chromosome mec, encodes methicillin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 2000, 44, 1549-1555.
9. Hegde, S. S.; Vetting, M. W.; Roderick, S. L.; Mitchenall, L. A.; Maxwell, A.; Takiff, H. E.; Blanchard, J. S. A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNA. Science 2005, 308, 1480-1483.
10. Burian, J.; Ramon-Garcia, S.; Sweet, G.; Gomez-Velasco, A.; Av- Gay, Y.; Thompson, C. J. The mycobacterial transcriptional regulator whiB7 gene links redox homeostasis and intrinsic antibiotic resistance. J. Biol. Chem. 2012, 287, 299-310.
11. Cohen, N. R.; Lobritz, M. A.; Collins, J. J. Microbial persistence and the road to drug resistance. Cell Host Microbe 2013, 13, 632-642.
12. Harms, A.; Maisonneuve, E.; Gerdes, K. Mechanisms of bacterial persistence during stress and antibiotic exposure. Science 2016, 354, No. aaf4268.
13. Nguyen, D.; Joshi-Datar, A.; Lepine, F.; Bauerle, E.; Olakanmi, O.; Beer, K.; McKay, G.; Siehnel, R.; Schafhauser, J.; Wang, Y.; Britigan, B. E.; Singh, P. K. Active starvation responses mediate antibiotic tolerance in biofilms and nutrient-limited bacteria. Science 2011, 334, 982-986.
14. Maisonneuve, E.; Castro-Camargo, M.; Gerdes, K. (p)ppGpp controls bacterial persistence by stochastic induction of toxin-antitoxin activity. Cell 2013, 154, 1140-1150.
15. Amato, S. M.; Orman, M. A.; Brynildsen, M. P. Metabolic control of persister formation in Escherichia coli. Mol. Cell 2013, 50, 475-487.
16. Costerton, J. W.; Stewart, P. S.; Greenberg, E. P. Bacterial biofilms: a common cause of persistent infections. Science 1999, 284, 1318-1322.
17. Weiss, L. A.; Stallings, C. L. Essential roles for Mycobacterium tuberculosis Rel beyond the production of (p)ppGpp. J. Bacteriol. 2013, 195, 5629-5638.
18. Hauryliuk, V.; Atkinson, G. C.; Murakami, K. S.; Tenson, T.; Gerdes, K. Recent functional insights into the role of (p)ppGpp in bacterial physiology. Nat. Rev. Microbiol. 2015, 13, 298-309.
19. Wexselblatt, E.; Oppenheimer-Shaanan, Y.; Kaspy, I.; London, N.; Schueler-Furman, O.; Yavin, E.; Glaser, G.; Katzhendler, J.; Ben- Yehuda, S. Relacin, a novel antibacterial agent targeting the Stringent Response. PLoS Pathog. 2012, 8, No. e1002925.
20. Wexselblatt, E.; Kaspy, I.; Glaser, G.; Katzhendler, J.; Yavin, E. Design, synthesis and structure-activity relationship of novel Relacin analogs as inhibitors of Rel proteins. Eur. J. Med. Chem. 2013, 70, 497-504.
21. Syal, K.; Flentie, K.; Bhardwaj, N.; Maiti, K.; Jayaraman, N.; Stallings, C. L.; Chatterji, D. Synthetic (p)ppGpp Analogue Is an Inhibitor of Stringent Response in Mycobacteria. Antimicrob. Agents Chemother. 2017, 61, No. e00443.
22. Vilchèze, C.; Hartman, T.; Weinrick, B.; Jacobs, W. R., Jr. Mycobacterium tuberculosis is extraordinarily sensitive to killing by a vitamin C-induced Fenton reaction. Nat. Commun. 2013, 4, No. 1881.
23. Syal, K.; Bhardwaj, N.; Chatterji, D. Vitamin C targets (p)ppGpp synthesis leading to stalling of long-term survival and biofilm formation in Mycobacterium smegmatis. FEMS Microbiol. Lett. 2017, 364, No. fnw282.
24. Gaca, A. O.; Kudrin, P.; Colomer-Winter, C.; Beljantseva, J.; Liu, K.; Anderson, B.; Wang, J. D.; Rejman, D.; Potrykus, K.; Cashel, M.; Hauryliuk, V.; Lemos, J. A. From (p)ppGpp to (pp)pGpp: Characterization of Regulatory Effects of pGpp Synthesized by the Small Alarmone Synthetase of Enterococcus faecalis. J. Bacteriol. 2015, 197, 2908-2919.
25. Beljantseva, J.; Kudrin, P.; Andresen, L.; Shingler, V.; Atkinson, G. C.; Tenson, T.; Hauryliuk, V. Negative allosteric regulation of Enterococcus faecalis small alarmone synthetase RelQ by single-stranded RNA. Proc. Natl. Acad. Sci. U.S.A. 2017, 114, 3726-3731.
26. Hengge, R.; Grundling, A.; Jenal, U.; Ryan, R.; Yildiz, F. Bacterial Signal Transduction by Cyclic Di-GMP and Other Nucleotide Second Messengers. J. Bacteriol. 2016, 198, 15-26.
27. O'Toole, G.; Kaplan, H. B.; Kolter, R. Biofilm formation as microbial development. Annu. Rev. Microbiol. 2000, 54, 49-79.
28. Pletzer, D.; Hancock, R. E. Antibiofilm Peptides: Potential as Broad-Spectrum Agents. J. Bacteriol. 2016, 198, 2572-2578.
29. Overhage, J.; Campisano, A.; Bains, M.; Torfs, E. C.; Rehm, B. H.; Hancock, R. E. Human host defense peptide LL-37 prevents bacterial biofilm formation. Infect. Immun. 2008, 76, 4176-4782.
30. Haney, E. F.; Mansour, S. C.; Hilchie, A. L.; de la Fuente-Nunez, C.; Hancock, R. E. High throughput screening methods for assessing antibiofilm and immunomodulatory activities of synthetic peptides. Peptides 2015, 71, 276-285.
31. de la Fuente-Núñez, C.; Reffuveille, F.; Mansour, S. C.; Reckseidler-Zenteno, S. L.; Hernandez, D.; Brackman, G.; Coenye, T.; Hancock, R. E. D-enantiomeric peptides that eradicate wild-type and multidrug-resistant biofilms and protect against lethal Pseudomonas aeruginosa infections. Chem. Biol. 2015, 22, 196-205.
32. Andresen, L.; Tenson, T.; Hauryliuk, V. Cationic bactericidal peptide 1018 does not specifically target the stringent response alarmone (p)ppGpp. Sci. Rep. 2016, 6, No. 36549.
33. Silva, T.; Moreira, A. C.; Nazmi, K.; Moniz, T.; Vale, N.; Rangel, M.; Gomes, P.; Bolscher, J. G. M.; Rodrigues, P. N.; Bastos, M.; Gomes, M. S. Lactoferricin Peptides Increase Macrophages' Capacity To Kill Mycobacterium avium. mSphere 2017, 2, No. e00301.
34. Serganov, A.; Nudler, E. A decade of riboswitches. Cell 2013, 152, 17-24.
35. Lee, E. R.; Blount, K. F.; Breaker, R. R. Roseoflavin is a natural antibacterial compound that binds to FMN riboswitches and regulates gene expression. RNA Biol. 2009, 6, 187-194.
36. Howe, J. A.; Wang, H.; Fischmann, T. O.; Balibar, C. J.; Xiao, L.; Galgoci, A. M.; Malinverni, J. C.; Mayhood, T.; Villafania, A.; Nahvi, A.; Murgolo, N.; Barbieri, C. M.; Mann, P. A.; Carr, D.; Xia, E.; Zuck, P.; Riley, D.; Painter, R. E.; Walker, S. S.; Sherborne, B.; de Jesus, R.; Pan, W.; Plotkin, M. A.; Wu, J.; Rindgen, D.; Cummings, J.; Garlisi, C. G.; Zhang, R.; Sheth, P. R.; Gill, C. J.; Tang, H.; Roemer, T. Selective small-molecule inhibition of an RNA structural element. Nature 2015, 526, 672-677.
37. Colameco, S.; Elliot, M. A. Non-coding RNAs as antibiotic targets. Biochem. Pharmacol. 2017, 133, 29-42.
38. Miyakoshi, M.; Chao, Y.; Vogel, J. Regulatory small RNAs from the 3′ regions of bacterial mRNAs. Curr. Opin. Microbiol. 2015, 24, 132-139.
39. Michaux, C.; Hartke, A.; Martini, C.; Reiss, S.; Albrecht, D.; Budin-Verneuil, A.; Sanguinetti, M.; Engelmann, S.; Hain, T.; Verneuil, N.; Giard, J. C. Involvement of Enterococcus faecalis small RNAs in stress response and virulence. Infect. Immun. 2014, 82, 3599-3611.
40. El-Mowafi, S. A.; Alumasa, J. N.; Ades, S. E.; Keiler, K. C. Cellbased assay to identify inhibitors of the Hfq-sRNA regulatory pathway. Antimicrob. Agents Chemother. 2014, 58, 5500-5509.
41. Bald, D.; Villellas, C.; Lu, P.; Koul, A. Targeting Energy Metabolism in Mycobacterium tuberculosis, a New Paradigm in Antimycobacterial Drug Discovery. mBio 2017, 8, No. e00272.
42. Vilchèze, C.; Hartman, T.; Weinrick, B.; Jain, P.; Weisbrod, T. R.; Leung, L. W.; Freundlich, J. S.; Jacobs, W. R., Jr. Enhanced respiration prevents drug tolerance and drug resistance in Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 2017, 114, 4495-4500.
43. Coulson, G. B.; Johnson, B. K.; Zheng, H.; Colvin, C. J.; Fillinger, R. J.; Haiderer, E. R.; Hammer, N. D.; Abramovitch, R. B. Targeting Mycobacterium tuberculosis Sensitivity to Thiol Stress at Acidic pH Kills the Bacterium and Potentiates Antibiotics. Cell Chem. Biol. 2017, 24, No. 993.e4.
44. Wellington, S.; Nag, P. P.; Michalska, K.; Johnston, S. E.; Jedrzejczak, R. P.; Kaushik, V. K.; Clatworthy, A. E.; Siddiqi, N.; McCarren, P.; Bajrami, B.; Maltseva, N. I.; Combs, S.; Fisher, S. L.; Joachimiak, A.; Schreiber, S. L.; Hung, D. T. A small-molecule allosteric inhibitor of Mycobacterium tuberculosis tryptophan synthase. Nat. Chem. Biol. 2017, 13, 943-950.
45. Richter, M. F.; Drown, B. S.; Riley, A. P.; Garcia, A.; Shirai, T.; Svec, R. L.; Hergenrother, P. J. Predictive compound accumulation rules yield a broad-spectrum antibiotic. Nature 2017, 545, 299-304.
46. Blondiaux, N.; Moune, M.; Desroses, M.; Frita, R.; Flipo, M.; Mathys, V.; Soetaert, K.; Kiass, M.; Delorme, V.; Djaout, K.; Trebosc, V.; Kemmer, C.; Wintjens, R.; Wohlkonig, A.; Antoine, R.; Huot, L.; Hot, D.; Coscolla, M.; Feldmann, J.; Gagneux, S.; Locht, C.; Brodin, P.; Gitzinger, M.; Deprez, B.; Willand, N.; Baulard, A. R. Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420. Science 2017, 355, 1206-1211.